<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://octansnews.com/research/trustmark-quarterly-net-revenue-rises-2-4-to-207-1-million</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T16:30:34.346Z</news:publication_date>
      <news:title>Trustmark quarterly net revenue rises 2.4% to $207.1 million</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/lycia-therapeutics-10-owner-venrock-healthcare-capital-partners-iii-l-p-buys-645-000-of-shares</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:36:37.705Z</news:publication_date>
      <news:title>Lycia Therapeutics 10% owner Venrock Healthcare Capital Partners III L.P. buys $645,000 of shares</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/corebridge-financial-10-owner-nippon-life-insurance-co-buys-8-7-million-of-shares-2</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:36:29.918Z</news:publication_date>
      <news:title>Corebridge Financial 10% owner Nippon Life Insurance Co buys $8.7 million of shares</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/rapport-therapeutics-director-james-healy-buys-20-4-million-of-shares</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:36:21.325Z</news:publication_date>
      <news:title>Rapport Therapeutics director James Healy buys $20.4 million of shares</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/sec-filing-red-flags-week-of-oct-26-to-30-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:36:12.385Z</news:publication_date>
      <news:title>SEC filing red flags, week of Oct 26 to 30, 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/newell-brands-quarterly-revenue-rises-3-7-to-1-87-billion</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:36:02.183Z</news:publication_date>
      <news:title>Newell Brands quarterly revenue rises 3.7% to $1.87 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/capri-quarterly-revenue-falls-5-5-to-809-0-million</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:35:47.127Z</news:publication_date>
      <news:title>Capri quarterly revenue falls 5.5% to $809.0 million</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/cavco-industries-quarterly-revenue-rises-17-9-to-656-4-million</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:35:40.064Z</news:publication_date>
      <news:title>Cavco Industries quarterly revenue rises 17.9% to $656.4 million</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/lear-quarterly-revenue-rises-1-6-to-5-77-billion</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:35:31.679Z</news:publication_date>
      <news:title>Lear quarterly revenue rises 1.6% to $5.77 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/autonation-quarterly-revenue-falls-0-4-to-7-01-billion</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:35:10.197Z</news:publication_date>
      <news:title>AutoNation quarterly revenue falls 0.4% to $7.01 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/gates-industrial-quarterly-revenue-rises-5-6-to-903-6-million</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:35:02.342Z</news:publication_date>
      <news:title>Gates Industrial quarterly revenue rises 5.6% to $903.6 million</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/gaming-leisure-properties-quarterly-revenue-rises-9-5-to-435-4-million</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:34:49.100Z</news:publication_date>
      <news:title>Gaming &amp; Leisure Properties quarterly revenue rises 9.5% to $435.4 million</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/regeneron-pharmaceuticals-quarterly-revenue-jumps-36-3-to-5-12-billion</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:34:39.754Z</news:publication_date>
      <news:title>Regeneron Pharmaceuticals quarterly revenue jumps 36.3% to $5.12 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/general-dynamics-quarterly-revenue-rises-12-9-to-14-57-billion</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:34:27.557Z</news:publication_date>
      <news:title>General Dynamics quarterly revenue rises 12.9% to $14.57 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/colgate-palmolive-quarterly-revenue-rises-4-6-to-5-37-billion</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:34:20.836Z</news:publication_date>
      <news:title>Colgate Palmolive quarterly revenue rises 4.6% to $5.37 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://octansnews.com/research/abbvie-quarterly-revenue-rises-10-3-to-17-40-billion</loc>
    <news:news>
      <news:publication>
        <news:name>Octans Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T11:34:12.636Z</news:publication_date>
      <news:title>AbbVie quarterly revenue rises 10.3% to $17.40 billion</news:title>
    </news:news>
  </url>
</urlset>
